AI Summary
VRTX (VRTX) is currently trading at $477.33, up 3.84% in the last 24 hours. The P/E ratio of 33.3 suggests the market has high growth expectations. We maintain a HOLD rating pending clearer directional signals.
Price
Volume
P/E Ratio
Insider
Price Chart
Price Data
Fundamentals
Technical Analysis Summary
27 indicators analyzed
Technical signals are mixed with 9 bullish and 6 bearish indicators. Wait for clearer direction before taking new positions.
Technical Indicators
Momentum & trend signals
💡 Technical indicators are tools, not guarantees. Always combine with fundamental analysis.
MACD
(12, 26, 9)Bollinger Bands
Volatility & breakout detection
Stochastic Oscillator
Momentum indicator (14,3,3)
📊 Neutral: VRTX stochastic is in the middle range (86.7). Wait for %K to enter overbought (80+) or oversold (20-) zones for clearer signals.
Average True Range (ATR)
📊 Volatility increasing - consider wider stops to avoid getting stopped out.
On-Balance Volume (OBV)
Volume-based momentum indicator
📊 OBV is neutral: Volume is not confirming a strong trend. Wait for clearer signals before taking directional positions.
Pivot Points
Key Support & Resistance Levels
All Pivot Levels
Price is trading above the pivot point at $464.85, indicating bullish bias. Watch R1 ($471.96) as the next target.
⚠️ Wide range - higher volatility expected. Use wider stops.
Fibonacci Retracement
| Level | Price | Type | Distance |
|---|---|---|---|
| 0% | $519.68 | Resistance | -8.8% |
| 23.6% | $482.59 | Resistance | -1.1% |
| 38.2% | $459.64 | Support | +3.8% |
| 50%✦ | $441.09 | Support | +7.6% |
| 61.8%✦ | $422.54 | Support | +11.5% |
| 78.6% | $396.14 | Support | +17.1% |
| 100% | $362.50 | Support | +24.1% |
VWAP (Volume Weighted Avg Price)
Parabolic SAR
Stop and Reverse Indicator
📈 Uptrend intact (11 days). SAR support at $453.10. Trail stops below SAR.
Williams %R
📈 OVERBOUGHT: Williams %R at -13.3 indicates the stock is trading near its 14-day high. Strong momentum continues - may stay overbought in uptrends.
📊 CCI (Commodity Channel Index)
Momentum oscillator measuring price deviation
Strength: 60%
Previous CCI
+9.3
Typical Price
$471.54
SMA (20)
$463.34
Mean Deviation
$9.99
⏸️ NEUTRAL: CCI at 54.7 - price trading within normal range. Momentum improving - watch for +100 breakout for buy signal. Wait for CCI to break ±100 levels for clearer trend signals.
20-Day CCI History
🎯Aroon Indicator(25-period)
⏸️ CONSOLIDATION: Both Aroon indicators near 50 (Up: 16, Down: 48). No clear trend direction. Price is ranging - wait for a breakout. Watch for either Aroon to move above 70 for trend emergence.
📊 Rate of Change (ROC)Buy
BullishUltimate Oscillator
Multi-timeframe momentum (7, 14, 28)
Keltner Channels
ATR-based volatility bands
⏸️ NEUTRAL: Price 477.54 is in the middle of the channel (EMA: 465.62). Channel width: 11.5%, ATR: 2.8% of price. No clear trend - wait for clearer signals.
TTM Squeeze
John Carter's Volatility Breakout
📈 NO SQUEEZE - BULLISH MOMENTUM: No squeeze currently (bands expanded). Momentum is positive and rising (6.70) - bullish continuation likely. Watch for momentum to strengthen for confirmation.
Elder Ray (Bull/Bear Power)
Dr. Alexander Elder's Power Index
📊 In uptrend. Watch for Bear Power to stay negative and rise for continuation signals.
Force Index
Dr. Alexander Elder's Volume-Price Momentum
🔔 BULLISH CROSSOVER! Force Index crossed above zero with volume. Momentum shifting to bulls - consider entry on pullback.
Williams Alligator
Trend Direction & Strength
😋 Alligator is SATED - trend is losing momentum. Lines are converging. Previous bullish trend may be ending. Consider taking profits and wait for the next opportunity.
Donchian Channels
Richard Donchian's Breakout System (20-period)
Price at $477.54 is in the upper half of the 20-day Donchian Channel (429.00 - 485.00). Channel is stable with 12.3% width. Current trend: Sideways.
Supertrend
ATR-Based Trend Following
🟢 BULLISH CROSSOVER! Price $477.54 just crossed above Supertrend $433.72. This is a BUY signal. The Supertrend line now acts as dynamic support - trail stops below it.
Choppiness Index
Trend vs Range Detection (14-period)
⏳ TRANSITIONAL MARKET (CHOP: 46.6). The market is between trending and ranging. Choppiness is increasing (2.2 points). ⚠️ Choppiness increasing - trend may be ending. Be cautious with trend trades. Trading advice: WAIT for clearer signals or use smaller position sizes.
Valuation Metrics
Relative value indicators
💡 PEG < 1 suggests undervalued relative to growth • EV/EBITDA accounts for debt
Historical Returns
Price performance across timeframes
📈 Insight: Compare returns across timeframes to identify trends and momentum shifts.
Seasonality Analysis
Market Comparison
Performance vs S&P 500
Growth Metrics
Year-over-year performance
Growth rates calculated from trailing twelve months vs prior period
Analyst EPS Estimates
Consensus earnings projections
| Fiscal Year | Est. EPS | YoY Growth |
|---|---|---|
| FY26 | $17.53 | +22.3% |
| FY27 | $18.09 | +3.2% |
| FY28 | $22.64 | +25.2% |
Based on analyst consensus estimates. Actual results may vary.
Insider Activity
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
Recent News
Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica
Autologous Cell Therapy Market Size to Reach US$ 44.55 Billion by 2033 | Astute Analytica
Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets
Stock Market Today, Jan. 15: ImmunityBio Surges After Anktiva Revenue Jumps 700%
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
Prediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026
Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases
My 10 Top Stocks to Buy to Start the New Year Off Right
Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize
3 Supercharged Growth Stocks to Buy and Hold Into the 2030s
💪 Strengths
- ✓Healthy profit margins (31.3%)
- ✓Conservative debt levels provide stability
🚀 Opportunities
- →Market conditions could present buying opportunities
⚠️ Weaknesses
- !No significant weaknesses identified
🛑 Threats
- ✕Broader market volatility remains a risk
⚡ Catalysts
- ★Earnings releases and guidance updates
⚠️ Key Risks
- !Standard market and sector risks apply
Are you an AI agent?
Help improve this research! Submit corrections, updates, or suggestions via Moltbook.
AI Agent Feedback
Are you an AI agent? Help improve this analysis!